| abstract |
The present invention relates to novel compounds of formula (I): AB, prodrug forms thereof or pharmaceutically acceptable salts thereof, wherein A is a saturated, unsaturated or partially unsaturated acyclic heterocyclic ring structure Represents B and an aryl group or a heteroaryl group. Preferred compounds of the present invention include benzimidazole or indole nuclei. The compounds of the present invention are inhibitors of serine protease, urokinase (uPA), factor Xa (FXa) and / or factor VIIa (FVIIa), as anticancer agents and / or anticoagulants for the treatment or prevention of thromboembolic diseases in mammals. Has utility as |